Saturday, July 11, 2026
🇺🇸 FDA

Intelligence · Clinical pipeline

Phase I Pipeline Programs

First-in-human and early clinical safety studies in Phase I.

Programs 4,713
Sponsors 1,771
Drugs 4,798

Quick answer

NovaPharmaNews tracks 4,713 phase i pharmaceutical pipeline programs from ClinicalTrials.gov. First-in-human and early clinical safety studies in Phase I.

Top sponsors

Pipeline programs

Page 58 of 99

  1. MT-1-02

    Minoryx Therapeutics S.L.

    Adrenoleukodystrophy

    phase 1 small molecule active

    1 trial

  2. MT-1186

    Tanabe Pharma

    Healthy Adult Subjects

    phase 1 small molecule completed

    1 trial

  3. MT-401-OTS

    Marker Therapeutics

    Acute Myeloid Leukemia, in Relapse

    phase 1 small molecule active

    1 trial

  4. MT-601

    Marker Therapeutics

    Non-Hodgkin Lymphoma, Adult

    phase 1 small molecule active

    1 trial

  5. MT-601 dose 200 million cells

    Marker Therapeutics

    Pancreas Cancer

    phase 1 small molecule active

    1 trial

  6. MT203 80 mg or matching Placebo

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  7. MTL-CEBPA

    Hospital Authority, Hong Kong

    Advanced Hepatocellular Carcinoma

    phase 1 small molecule active

    1 trial

  8. MTX110

    Biodexa Pharmaceuticals Plc

    Recurrent Glioblastoma

    phase 1 small molecule terminated

    1 trial

  9. MUNC13.4-CD34 suspension, MUNC13.4-T3 suspension

    Pari Pharma GmbH

    Familial Hemophagocytic Lymphohistiocytosis (FHL)

    phase 1 small molecule active

    1 trial

  10. MV-LASV

    Harmony Biosciences Holdings

    Lassa Virus Infection

    phase 1 mab completed

    1 trial

  11. MVA-NP+M1

    Barinthus Biotherapeutics plc.

    Human Volunteers

    phase 1 mab completed

    1 trial

  12. MVC-101

    Takeda

    Solid Tumour

    phase 1 mab terminated

    1 trial

  13. MWN109 tablet

    Shanghai University of Traditional Chinese Medicine

    Overweight or Obesity

    phase 1 small molecule active

    1 trial

  14. MZE001

    Maze Therapeutics

    Healthy

    phase 1 small molecule completed

    1 trial

  15. Macitentan 10 mg tablet, once daily.

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Coronary Microvascular Angina

    phase 1 small molecule active

    1 trial

  16. Magellan®

    United Therapeutics Europe Ltd

    Acute Burns

    phase 1 other active

    1 trial

  17. Mammaglobin-A DNA Vaccine

    United Therapeutics Europe Ltd

    Breast Cancer

    phase 1 mab active

    1 trial

  18. ManNAc

    Ultragenyx UK Limited

    Hereditary Inclusion Body Myopathy (HIBM)

    phase 1 small molecule completed

    1 trial

  19. MapMySmoke

    United Therapeutics Europe Ltd

    Smoking

    phase 1 other active

    1 trial

  20. Maribavir

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    2 trials

  21. Maribavir (400 mg)

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  22. Maribavir Commercial Tablet Formulation

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  23. Marijuana

    BRIGHT MINDS BIOSCIENCES INC.

    Cannabis

    phase 1 small molecule completed

    1 trial

  24. Marijuana via vape device

    BRIGHT MINDS BIOSCIENCES INC.

    Cigarette Smoking-Related Carcinoma

    phase 1 small molecule active

    1 trial

  25. Marinol 10Mg Capsule TMS Sham

    BRIGHT MINDS BIOSCIENCES INC.

    Neurosciences

    phase 1 small molecule completed

    1 trial

  26. MarzAA (marzeptacog alfa [activated])

    CATALYST PHARMACEUTICALS, INC.

    Hemophilia A

    phase 1 mab completed

    1 trial

  27. Mass Balance Study of [14C] ABBV-932 in Healthy Male Volunteers

    AbbVie Deutschland GmbH & Co. KG

    Healthy Volunteers

    phase 1 other active

    1 trial

  28. Mass Balance and Absolute Oral Bioavailability of [14C]VH4524184

    ViiV Healthcare Pty Ltd

    human immunodeficiency virus (HIV)

    phase 1 other active

    1 trial

  29. Mavorixafor

    X4 Pharmaceuticals, Inc

    Healthy Participants

    phase 1 small molecule completed

    1 trial

  30. Mavorixafor

    X4 Pharmaceuticals, Inc

    Hepatic Insufficiency

    phase 1 small molecule active

    1 trial

  31. Mavorixafor

    X4 Pharmaceuticals, Inc

    Waldenstrom's Macroglobulinemia

    phase 1 small molecule completed

    1 trial

  32. Medium THC

    BRIGHT MINDS BIOSCIENCES INC.

    Marijuana Impairment

    phase 1 small molecule completed

    1 trial

  33. Meloxicam 15 mg Tablets

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule completed

    2 trials

  34. Memantine

    BRIGHT MINDS BIOSCIENCES INC.

    Tobacco Use Disorder

    phase 1 small molecule completed

    1 trial

  35. Meningococcal ACYW135 Polysaccharide Conjugate Vaccine

    BRIGHT MINDS BIOSCIENCES INC.

    Meningitis, Meningococcal

    phase 1 mab active

    1 trial

  36. Menopur 150 international units

    NORTHWEST BIOTHERAPEUTICS INC

    Pregnancy

    phase 1 small molecule terminated

    1 trial

  37. Mepolizumab

    BRIGHT MINDS BIOSCIENCES INC.

    Healthy Subjects

    phase 1 mab completed

    1 trial

  38. Mesalamine

    Takeda

    Healthy

    phase 1 small molecule completed

    1 trial

  39. Mesenchymal Stem Cell Infusion

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Immune Effector Cell Associated Hematotoxicity

    phase 1 mab active

    1 trial

  40. Metabolically Armed CD19 CAR-T cells

    Anhui Provincial Hospital

    Acute Lymphoblastic Leukemia

    phase 1 small molecule active

    1 trial

  41. Metformin

    The First People's Hospital of Lianyungang

    Type2 Diabetes

    phase 1 small molecule active

    1 trial

  42. Metformin

    United Therapeutics Europe Ltd

    Tendinopathy

    phase 1 small molecule active

    1 trial

  43. Methadone

    BRIGHT MINDS BIOSCIENCES INC.

    Opiate-Related Disorders

    phase 1 small molecule completed

    1 trial

  44. Methamphetamine

    BRIGHT MINDS BIOSCIENCES INC.

    Stimulant Use

    phase 1 small molecule completed

    1 trial

  45. Methamphetamine

    BRIGHT MINDS BIOSCIENCES INC.

    Methamphetamine Use Disorder

    phase 1 small molecule completed

    1 trial

  46. Methamphetamine (Desoxyn®)

    BRIGHT MINDS BIOSCIENCES INC.

    Methamphetamine Abuse

    phase 1 small molecule completed

    1 trial

  47. Methosulide

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Healthy

    phase 1 small molecule completed

    1 trial

  48. Methotrexate

    Sana Biotechnology

    Chronic Plaque Psoriasis

    phase 1 small molecule active

    1 trial

Frequently asked questions

How many Phase I pipeline programs are in the directory?

4,713 published programs match this development stage in our ClinicalTrials.gov index.

What defines this pipeline stage?

Phase and status reflect ClinicalTrials.gov registry fields at last sync. See our clinical trial phases reference for methodology.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.